Cencora EBITDA 2010-2023 | COR
Cencora annual and quarterly EBITDA history from 2010 to 2023. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Cencora EBITDA for the quarter ending December 31, 2023 was $1.101B, a 36.21% increase year-over-year.
- Cencora EBITDA for the twelve months ending December 31, 2023 was $3.614B, a 15.08% increase year-over-year.
- Cencora 2023 annual EBITDA was $3.322B, a 5.21% increase from 2022.
- Cencora 2022 annual EBITDA was $3.157B, a 8.84% increase from 2021.
- Cencora 2021 annual EBITDA was $2.901B, a 166.44% decline from 2020.
| Cencora Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $3,322 |
| 2022 | $3,157 |
| 2021 | $2,901 |
| 2020 | $-4,366 |
| 2019 | $1,609 |
| 2018 | $2,013 |
| 2017 | $1,493 |
| 2016 | $1,918 |
| 2015 | $678 |
| 2014 | $979 |
| 2013 | $1,069 |
| 2012 | $1,444 |
| 2011 | $1,296 |
| 2010 | $1,181 |
| 2009 | $978 |
| Cencora Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-12-31 | $1,101 |
| 2023-09-30 | $761 |
| 2023-06-30 | $947 |
| 2023-03-31 | $805 |
| 2022-12-31 | $809 |
| 2022-09-30 | $710 |
| 2022-06-30 | $663 |
| 2022-03-31 | $960 |
| 2021-12-31 | $825 |
| 2021-09-30 | $768 |
| 2021-06-30 | $752 |
| 2021-03-31 | $729 |
| 2020-12-31 | $652 |
| 2020-09-30 | $-5,652 |
| 2020-06-30 | $504 |
| 2020-03-31 | $410 |
| 2019-12-31 | $373 |
| 2019-09-30 | $293 |
| 2019-06-30 | $519 |
| 2019-03-31 | $184 |
| 2018-12-31 | $613 |
| 2018-09-30 | $341 |
| 2018-06-30 | $535 |
| 2018-03-31 | $607 |
| 2017-12-31 | $531 |
| 2017-09-30 | $-23 |
| 2017-06-30 | $278 |
| 2017-03-31 | $731 |
| 2016-12-31 | $506 |
| 2016-09-30 | $328 |
| 2016-06-30 | $629 |
| 2016-03-31 | $1,050 |
| 2015-12-31 | $-89 |
| 2015-09-30 | $620 |
| 2015-06-30 | $403 |
| 2015-03-31 | $-308 |
| 2014-12-31 | $-37 |
| 2014-09-30 | $266 |
| 2014-06-30 | $160 |
| 2014-03-31 | $347 |
| 2013-12-31 | $205 |
| 2013-09-30 | $158 |
| 2013-06-30 | $178 |
| 2013-03-31 | $392 |
| 2012-12-31 | $341 |
| 2012-09-30 | $361 |
| 2012-06-30 | $361 |
| 2012-03-31 | $409 |
| 2011-12-31 | $313 |
| 2011-09-30 | $245 |
| 2011-06-30 | $349 |
| 2011-03-31 | $396 |
| 2010-12-31 | $307 |
| 2010-09-30 | $250 |
| 2010-06-30 | $308 |
| 2010-03-31 | $336 |
| 2009-12-31 | $288 |
| 2009-09-30 | $250 |
| 2009-06-30 | $237 |
| 2009-03-31 | $271 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $47.529B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $117.972B | 15.31 |
| ICON (ICLR) | Ireland | $24.256B | 23.92 |
| DiDi Global (DIDIY) | China | $21.667B | 0.00 |
| Avantor (AVTR) | United States | $16.686B | 22.99 |
| Viatris (VTRS) | United States | $13.340B | 3.81 |
| CochLear (CHEOY) | $13.217B | 0.00 | |
| Revvity (RVTY) | United States | $12.387B | 21.57 |
| Charles River Laboratories (CRL) | United States | $11.968B | 21.82 |
| Medpace Holdings (MEDP) | United States | $11.930B | 43.36 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.918B | 0.00 |
| Natera (NTRA) | United States | $10.907B | 0.00 |
| Solventum (SOLV) | $10.687B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.887B | 51.46 |
| Bausch + Lomb (BLCO) | Canada | $4.944B | 19.01 |
| Doximity (DOCS) | United States | $4.675B | 34.81 |
| Organon (OGN) | United States | $4.548B | 4.40 |
| Progyny (PGNY) | United States | $3.209B | 53.85 |
| Surgery Partners (SGRY) | United States | $3.128B | 29.07 |
| Sotera Health (SHC) | United States | $3.083B | 15.12 |
| Life Times (LTH) | United States | $2.793B | 30.87 |
| GoodRx Holdings (GDRX) | United States | $2.575B | 130.40 |
| Premier (PINC) | United States | $2.480B | 9.08 |
| Teladoc Health (TDOC) | United States | $2.223B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.153B | 6.96 |
| Agilon Health (AGL) | United States | $1.835B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.809B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.421B | 0.00 | |
| Agiliti (AGTI) | United States | $1.364B | 22.27 |
| NovoCure (NVCR) | Jersey | $1.341B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.926B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.750B | 7.76 |
| Embecta (EMBC) | United States | $0.596B | 3.94 |
| Auna S.A (AUNA) | Luxembourg | $0.562B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.556B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.544B | 0.00 |
| Enhabit (EHAB) | United States | $0.514B | 46.54 |
| MultiPlan (MPLN) | United States | $0.469B | 0.00 |
| Beauty Health (SKIN) | United States | $0.437B | 0.00 |
| CareDx (CDNA) | United States | $0.406B | 0.00 |
| LifeMD (LFMD) | United States | $0.400B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.366B | 0.00 |
| DocGo (DCGO) | United States | $0.340B | 54.33 |
| Sera Prognostics (SERA) | United States | $0.318B | 0.00 |
| ModivCare (MODV) | United States | $0.310B | 4.11 |
| Ascend Wellness Holdings (AAWH) | United States | $0.252B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.250B | 0.00 |
| Sharecare (SHCR) | United States | $0.240B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.114B | 38.17 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeueHealth (NEUE) | United States | $0.049B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.039B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.018B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |